Crossllnklng CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

Journal of Experimental Medicine

Volumn 176, Issue 4, 1992, Pages 1099-1106

  Banda, Nirmal K ^a   Bernier, Jacques ^c   Kurahara, David K ^a   Kurrle, Roland ^d   Haigwood, Nancy ^e   Sekaly, Rafik P ^c   Finkel, Terri Helman ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d Behringwerke AG   (Germany)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; T LYMPHOCYTE RECEPTOR; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CROSS LINKING; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD4; APOPTOSIS; CELLS, CULTURED; CROSS-LINKING REAGENTS; DNA DAMAGE; GAMMA RAYS; HIV; HIV ENVELOPE PROTEIN GP120; HUMAN; LYMPHOCYTE ACTIVATION; PROTEIN BINDING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS;

EID: 0026784923     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.176.4.1099     Document Type: Article

References (67)

1. Dalgleish, A.G., P.C. Beverley, P.R. Chapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (Lond.). 312:763.
2. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.-C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (Lond.). 312:767.
3. McDougal, J.S., A. Mawle, S.P. Cort, J.K. Nicholson, G.D. Cross, J.A Scheppler-Campbell, D. Hicks, and J. Sligh. 1985. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J. Immunol 135:3151.
4. Maddon, P.J., A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:333.
5. Terai, C., R.S. Kornbluth, C.D. Pauza, D.D. Richman, and D.A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710.
6. Harper, M.E., L.M. Marselle, R.C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T-lympho-tropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Set. USA. 83:772.
7. Richman, D.D., J.A. McCutchan, and S.A. Spector. 1987. Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization. J. Infect. Dis. 156:823.
8. Ranki, A., S.-L. Valle, M. Krohn, J. Antonen, J.-P. Allain, M. Leuther, G. Franchini, and K. Krohn. 1987. Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet. ii:589.
9. Fauci, A.S. 1988. The human immunodeficiency virus: infec-tivity and mechanisms of pathogenesis. Science (Wash. DC). 239:617.
10. Schnittman, S.M., M.C. Psallidopoulos, H.C. Lane, L. Thompson, M. Baseler, F. Massari, C.H. Fox, N.P. Salzman, and A.S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (Wash. DC). 245:305.
11. Shearer, G.M., D.C. Bernstein, K.S.K. Tung, C.S. Via, R. Redfield, S.Z. Salahuddin, and R.C. Gallo. 1986. A model for the selective loss of major histocompatibility complex selfrestricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137:2514.
12. Weinhold, K.J., H.K. Lyerly, S.D. Stanley, A.A. Austin, T.J. Matthews, and D.P. Bolognesi. 1989. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091.
13. Lasky, L.A., G. Nakamura, D.H. Smith, C. Fennie, C. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D.J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gpl20 glycoprotein critical for interaction with the CD4 receptor. Cell. 50:975.
14. Smith, D.H., R.A. Byrn, S.A. Marsters, T. Gregory, J.E. Groopman, and D.J. Capon. 1987. Blocking of HIV-1 infec-tivity by a soluble, secreted form of the CD4 antigen. Science (Wash. DC). 238:1704.
15. Lane, H.C., J.M. Depper, W.C. Greene, G. Whalen, T.A. Wald-mann, and A.S. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79.
16. Newell, M.K., L.J. Haughn, C.R. Maroun, and M.H. Julius. 1990. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature (Lond.). 347:286.
17. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.). 284:555.
18. Sellins, K.S., and J.J. Cohen. 1987. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139:3199.
19. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331.
20. Pellegrino, M.A., S. Ferrone, and A.N. Theofilopoulos. 1976. Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiouronium bromide (AET)-treated sheep red blood cells with monkey red blood cells. J. Immunol. Methods. 11:273.
21. Lura, L.G., M. Orcutt-Thordarson, M.C. Seigneuret, and J.A. Hansen. 1982. In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3). Ceil. Immunol. 72:122.
22. Levy, J.A., A.D. Hoffman, S.M. Kramer, J.A. Landis, J.M. Shimabukuro, and L.S. Oshiro. 1984. Isolation of lym-phocytopathic retroviruses from San Francisco patients with AIDS. Science (Wash. DC). 225:840.
23. Sanchez-Pescador, R., M.D. Power, P.J. Barr, K.S. Steimer, M.M. Stempien, S.L. Brown-Shimer, W.W. Gee, A. Renard, A. Randolph, J.A. Levy, D. Dina, and P.A. Lucin. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science (Wish. DC). 227:484.
24. Haigwood, N.L., C.B. Barker, K.W. Higgins, P.V. Skiles, G.K. Moore, K. A. Mann, D.R. Lee, J.W. Eichberg, and K.S. Steimer. 1990. Evidence for neutralizing antibodies directed against conformational epitopes of HIV-1 gpl20. In Vaccines 90. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 313-320.
25. Steimer, K.S., G.A. van Nest, N.L. Haigwood, E.M. Tillson, George-Nascimento, P.J. Barr, and D. Dina. 1988. Recombinant env and gag polypeptides in characterizing HIV-l-neutralizing antibodies. In Vaccines 88. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 347-355.
26. Lasky, L.A., J.E. Groopman, C.W. Fennie, P.M. Benz, D.J. Capon, D.J. Dowbenko, G.R. Nakamura, W.M. Nunes, M.E. Renz, and P.W. Brennan. 1986. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science (Wish. DC). 233:209.
27. Sattentau, Q.J., A.G. Dalgleish, R.A. Weiss, and P.C. Beverley. 1986. Epitopes of the CD4 antigen and HIV infection. Science (Wash. DC). 234:1120.
28. Borst, J., J.J.M. van Dongen, E. de Vries, W.M. Comans-Bitter, M.J.D. van Tol, J.M. Vossen, and R. Kurrle. 1990. BMA-031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states. Hum. Immunol. 29:175.
29. Smith, C.A., G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J.T. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (Lond.). 337:181.
30. Reed, K.C., and D.A. Mann. 1985. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids. Res. 13:7207.
31. Church, G.M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1991.
32. Burton, K. 1956. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:315.
33. Shi, Y.F., B.M. Sahai, and D.R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature (Lond.). 339:625.
34. Duke, R.C., and J.J. Cohen. 1986. IL-2 addition: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 5:289.
35. Waldmann, H. 1989. Manipulation of T-cell responses with monoclonal antibodies. Annu. Rev. Immunol. 7:407.
36. Cohen, J.J. 1991. Programmed cell death in the immune system. Adv. Immun. 50:55.
37. + T-hepler cells. Am. J. Pathol. 140:15.
38. Weiss, R.A., P.R. Clapham, R. Cheingsong-Popov, A.G. Dalgleish, C.A. Came, I.V.D. Weller, and R.S. Tedder. 1985. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (Lond.). 316:69.
39. Robert-Guroff, M., M. Brown, and R.C. Gallo. 1985. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature (Lond.). 316:72.
40. Ho, D.D., M.G. Saragadharan, M.S. Hirsch, R.T. Schooley, T.R. Rota, R.C. Kennedy, T.C. Chanh, and V.L. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61:2024.
41. Cheng-Mayer, C., J. Homsy, L.A. Evans, and J.A. Levy. 1988. Identification of human immunodeficiency vims subtypes with distinct patterns of sensitivity to serum neutralization. Proc. Natl. Acad. Sci. USA. 85:2815.
42. Rook, A.H., H.C. Lane, T. Folks, S. McCoy, H. Alter, and A.S. Fauci. 1987. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J. Immunol. 138:1064.
43. Ljunggren, K., B. Bottiger, G. Biberfield, A. Karlson, E.-M. Fenyo, and M. Jondal. 1987. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency vims. Presence at different clinical stages.J. Immunol. 139:2263.
44. Ojo-Amaize, E.A., P. Nishanian, D.E. Keith Jr., R.L. Houghton, D.F. Heitjan, J.L. Fahey, and J.V. Giorgi. 1987. Antibodies to human immunodeficiency vims in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J. Immunol. 139:2458.
45. Blumberg, R.S., T. Paradis, K.L. Hartshorn, M. Vogt, D.D. Ho, M.S. Hirsch, J. Leban, V.L. Sato, and R.T. Schooley. 1987. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency vims. J. Infect. Dis. 156:878.
46. Shepp, D.H., S. Chakrabarti, B. Moss, and G.V. Quinnan Jr. 1988. Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency vims. J. Infect. Dis. 157:1260.
47. Hornsey, J., M. Tateno, and J.A. Levy. 1988. Antibody-dependent enhancement of HIV infection [letter]. Lancet. i:1285.
48. Takeda, A., C.U. Tuazon, and F.A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (Wash. DC). 242:580.
49. Halstead, S.B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science (Wash. DC). 239:476.
50. Robinson, W.E.J., D.C. Montefiori, and W.M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency vims type 1 infection. Lancet. i:790.
51. Homsy, J., M. Meyer, M. Tateno, S. Clarkson, and J.A. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science (Wish. DC). 244:1357.
52. Mittler, R.S., and M.K. Hoffmann. 1989. Synergism between HIV gpl20 and gpl20-specific antibody in blocking human T cell activation. Science (Wish. DC). 245:1380.
53. Cmikshank, W.W., D.M. Center, S.W. Pyle, and H. Korn-feld. 1990. Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking. Biomed. & Pharmacother. 44:5.
54. Schneider, J., O. Kaaden, T.D. Copeland, S. Oroszlan, and G. Hunsmann. 1986. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gpl20 of the human immunodeficiency vims. J. Gen. Virol. 67:2533.
55. Pyle, S.W., J.W.J. Bess, W.G. Robey, P.J. Fischinger, R.V. Gilden, and L.O. Arthur. 1987. Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HlV)-infected H9 cells. AIDS Res. Hum. Retroviruses. 3:387.
56. Kieny, M.P., G. Rautmann, D. Schmitt, K. Dott, S. Wain-Hobson, M. Alizon, M. Girard, S. Chamaret, A. Laurent, L. Montagnier, and J.P. Lecocq. 1986. Bio/Technology. 4:790.
57. Oh, S.-Y., W.W. Cruikshank, J. Raina, G.C. Blanchard, W.H. Adler, J. Walker, and H. Komfeld. 1992. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquired Immune Defic. Syndr. 5:251.
58. Lyerly, H.K., T.J. Matthews, A.J. Langlois, D.P. Bolognesi, and K.J. Weinhold. 1987. Human T-cell lymphotropic virus IIIB glycoprotein (gpl20) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc. Natl. Acad. Sci. USA. 84:4601.
59. + cell depletion. Cell. 54:561.
60. Cole, B.C., and C.L. Arkin. 1991. The mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today. 12:271.
61. Choi, Y.W., J.W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumor virus. Nature (Lond.). 350:203.
62. Hugin, A.W., M.S. Vacchio, and H.C. Morse III. 1991. A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science (Wash. DC). 252:424.
63. Imberti, L., A. Sottini, A. Bettinardi, M. Puoti, and D. Primi. 1991. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science (Wish. DC). 254:860.
64. Duesberg, P.H. 1987. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res. 47:1199.
65. Kessler, H.A., B. Blaauw, J. Spear, D.A. Paul, L.A. Falk, and A. Landay. 1987. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. J. Am. Med. Assoc. 258:1196.
66. Potter, T.A., T.V. Rajan, R.F. Dick II, and J.A. Bluestone. 1989. Substitutions at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature (Lond.). 337:73.
67. Lopes, J., and P. Shelton. 1991. The SAS System for Linear Models. SAS Institute, Inc., Cary, NC. 272-274.